Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Chambers of the Heart01:16

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aggressive coiling of aortopulmonary collaterals in single-ventricle patients is warranted.

Pediatric cardiology·2010
Same author

Catheter-based therapy for small preterm infants with pulmonary atresia/intact ventricular septum.

Congenital heart disease·2009
Same author

The argument for aggressive coiling of aortopulmonary collaterals in single ventricle patients.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2009
Same author

A premounted stent that can be implanted in infants and re-dilated to 20 mm: introducing the Edwards Valeo Lifestent.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2009
Same author

Use of a percutaneous septal occlusion device to exclude a juxta-renal pseudoaneurysm of the abdominal aorta.

Journal of vascular surgery·2008
Same journal

Cardiac Imaging Predictors of Ventricular Recovery in Pediatric Patients Undergoing Aortic Valve Intervention for Regurgitation.

Pediatric cardiology·2026
Same journal

Holter-Based Heart Rate Variability Distinguishes Adolescent Postural Orthostatic Tachycardia Syndrome from Healthy Controls.

Pediatric cardiology·2026
Same journal

Left Atrial Function in Children with Cancer Prior to Start of Chemotherapy: A Speckle Echocardiography Analysis.

Pediatric cardiology·2026
Same journal

Early Improvement in Cardiac Autonomic Modulation After a Recreational Physical Training Program in Healthy Children.

Pediatric cardiology·2026
Same journal

Beyond Body Mass Index: Skeletal Muscle Mass as a Marker of Physiologic Reserve in Fontan Circulation.

Pediatric cardiology·2026
Same journal

Geographical and Language-Based Factors Associated with Neurodevelopmental Follow-Up in Children with Congenital Heart Disease.

Pediatric cardiology·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:29

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

Fontan "Ten Commandments" revisited and revised.

Herbert J Stern

    Pediatric Cardiology
    |October 21, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Choussat's "Ten Commandments" for Fontan candidates need updating. Achieving perfection is now the sole criterion for optimal long-term survival in Fontan patients.

    More Related Videos

    Technical Considerations and Approach to Redo Foregut Surgery
    04:14

    Technical Considerations and Approach to Redo Foregut Surgery

    Published on: September 22, 2023

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
    06:29

    Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

    Published on: May 2, 2025

    Technical Considerations and Approach to Redo Foregut Surgery
    04:14

    Technical Considerations and Approach to Redo Foregut Surgery

    Published on: September 22, 2023

    Area of Science:

    • Cardiology
    • Pediatric Cardiology
    • Congenital Heart Disease

    Background:

    • Choussat's
    • Ten Commandments
    • established criteria for ideal Fontan candidates in 1977.
    • These guidelines aimed to optimize outcomes for patients with single ventricle physiology.

    Discussion:

    • Historical analysis reveals that strict adherence to all original commandments does not guarantee excellent long-term survival.
    • The evolving understanding of Fontan physiology necessitates a re-evaluation of selection criteria.
    • Focusing solely on perfection addresses the complexity of achieving superior long-term outcomes.

    Key Insights:

    • The original Fontan candidate selection criteria require modification.
    • Long-term survival improvement should be the primary endpoint for evaluating Fontan candidates.
    • A singular, stringent criterion of "perfection" is proposed to encompass all necessary factors for optimal Fontan outcomes.

    Outlook:

    • Future research should validate the proposed "perfection" criterion.
    • Refined patient selection may lead to improved long-term survival rates post-Fontan procedure.
    • This updated approach could enhance the management of complex congenital heart disease.